2652.HK · CF PHARMTECH
Hong Kong · RS rating 2 · As of 2026-11-03
| Price | 5.07 HKD |
|---|---|
| 1-day change | -4.1% |
| RS rating (overall / 1M / 3M / 12M) | 2 / 9 / 2 / 3 |
| Stage | Declining |
| Composite / Minervini / CANSLIM score | 24 / 3 / 15 |
| Industry group (rank) | Pharma & Biotech (27) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | -48.5% |
| Distance from 52-week high | +87.0% |
| Market cap (USD) | $291.9M |